ObjectiveThis study aimed to assess whether currently used dosages of vancomycin for
treatment of serious gram-positive bacterial infections in intensive care
unit patients provided initial therapeutic vancomycin trough levels and to
examine possible factors associated with the presence of adequate initial
vancomycin trough levels in these patients.MethodsA prospective descriptive study with convenience sampling was performed.
Nursing note and medical record data were collected from September 2013 to
July 2014 for patients who met inclusion criteria. Eighty-three patients
were included. Initial vancomycin trough levels were obtained immediately
before vancomycin fourth dose. Acute kidney injury was defined as an
increase of at least 0.3mg/dL in serum creatinine within 48 hours.ResultsConsidering vancomycin trough levels recommended for serious gram-positive
infection treatment (15 - 20µg/mL), patients were categorized as
presenting with low, adequate, and high vancomycin trough levels (35
[42.2%], 18 [21.7%], and 30 [36.1%] patients, respectively). Acute kidney
injury patients had significantly greater vancomycin trough levels (p =
0.0055, with significance for a trend, p = 0.0023).ConclusionSurprisingly, more than 40% of the patients did not reach an effective
initial vancomycin trough level. Studies on pharmacokinetic and dosage
regimens of vancomycin in intensive care unit patients are necessary to
circumvent this high proportion of failures to obtain adequate initial
vancomycin trough levels. Vancomycin use without trough serum level
monitoring in critically ill patients should be discouraged.